合成路线1
该中间体在本合成路线中的序号:
(A) The reaction of methyl N-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate (I) with phenylmagnesium bromide (A) gives methyl 1-methyl-4-phenylpiperidine-3-carboxylate (II), which is reduced with LiAlH4 yielding 1-methyl-3-hydroxymethyl-4-phenylpiperidine (III), which, in turn is resolved into its optical isomers. The alcohol (III) is esterified with methanesulfonyl chloride in pyridine affording 3-(methansulfonyloxymethyl)-1-methyl-4-phenylpiperidine (IV), which is finally condensed with p-methoxyphenol (B) by means of sodium methoxide in refluxing methanol.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(B) |
32744 |
4-methoxyphenol
|
150-76-5 |
C7H8O2 |
详情 | 详情
|
(I) |
38648 |
methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate
|
|
C8H13NO2 |
详情 |
详情
|
(II) |
40118 |
methyl (3R,4S)-1-methyl-4-phenyl-3-piperidinecarboxylate
|
|
C14H19NO2 |
详情 |
详情
|
(III) |
40119 |
[(3R,4S)-1-methyl-4-phenylpiperidinyl]methanol
|
|
C13H19NO |
详情 |
详情
|
(IV) |
40120 |
(3R,4S)-1-methyl-3-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-4-phenylpiperidine
|
|
C16H25NOS |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(E) The starting benzophenone (I) can also be obtained in several different ways:
a) By a Friedel-Crafts reaction of p-chloroaniline (X) and benzoyl chloride (D).
b) By reaction of 5-chloroanthranilic acid (XI) with acetic anhydride to the bicyclic compound (XII), which is then submitted to a Grignard reaction with phenylmagnesium bromide (E).
c) By oxidation of 2,3-diphenyl-5-chloroindole (XIII) with CrO3 to the N-benzoylbenzophenone (XIV), followed by debenzoylation with NaOH.
【1】
Topliss, J.G.; 1-Polyhalogenoalkyl-2-oxo-1,3-dihydro-2H-14-benzodiazepines. US 3429874 .
|
【2】
Topliss, J.G.; 2-Polyfluoroweralkyl benzophenones. US 3641147 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(E) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
10279 |
(2-Amino-5-chlorophenyl)(phenyl)methanone; 2-Amino-5-chlorobenzophenone
|
719-59-5 |
C13H10ClNO |
详情 | 详情
|
(X) |
12034 |
4-Chlorophenylamine; 4-Chloroaniline; p-Chloroaniline
|
106-47-8 |
C6H6ClN |
详情 | 详情
|
(XI) |
10285 |
2-Amino-5-chlorobenzoic acid
|
635-21-2 |
C7H6ClNO2 |
详情 | 详情
|
(XII) |
33853 |
6-chloro-2-methyl-4H-3,1-benzoxazin-4-one
|
|
C9H6ClNO2 |
详情 |
详情
|
(XIII) |
33854 |
5-chloro-2,3-diphenyl-1H-indole
|
|
C20H14ClN |
详情 |
详情
|
(XIV) |
33855 |
N-(2-benzoyl-4-chlorophenyl)benzamide
|
|
C20H14ClNO2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) The Grignard reaction of phenylmagnesium bromide (I) with 11C labeled CO2 (II) in THF gives the radiolabeled benzoic acid (III), which is treated with phthaloyl dichloride (IV) in the same solvent to yield radiolabeled benzoyl chloride (V). Finally, this compound is treated with N-debenzoylated paclitaxel (VI) in acetonitrile to afford the target radiolabeled paclitaxel.
【1】
Ravert, H.T.; et al.; Radiosynthesis of [11C]paclitaxel. J Label Compd Radiopharm 2002, 45, 6, 471.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(III) |
10202 |
Benzoic acid
|
65-85-0 |
C7H6O2 |
详情 | 详情
|
(III) |
55347 |
benzoic acid
|
|
C7H6O2 |
详情 |
详情
|
(IV) |
23811 |
phthaloyl dichloride;1,2-Benzenedicarbonyl dichloride;o-Phthaloyl chloride |
88-95-9 |
C8H4Cl2O2 |
详情 | 详情
|
(V) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(V) |
55348 |
benzoyl chloride
|
|
C7H5ClO |
详情 |
详情
|
(VI) |
10729 |
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetoxy)-15-[[(2R,3S)-3-amino-2-hydroxy-3-phenylpropanoyl]oxy]-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0(3,10).0(4,7)]heptadec-13-en-2-yl benzoate
|
|
C40H47NO13 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(A) Grignard addition of phenylmagnesium bromide to (+)-camphor (I) yielded the endo-alcohol (II), which was reacted with 1-dimethylamino-2-chloroethane (III) to give the base corresponding to EGYT-3886. EGYT-3886 is the 2-(E)-butenedioate salt (1:1).
【1】
Budai, Z.; Magdanyi, L.; Lay, A.; Mezei, T.; Grasser, K.; Petocz, L.; Kosoczky, I. (Egis Pharmaceuticals Ltd.); Basic ethers and pharmaceutical compsns. containing the same. US 4342762 .
|
【2】
Berényi, E.; Baskó, G.; Fekete, M.; Nógrádi, M.; EGYT-3886. Drugs Fut 1990, 15, 12, 1174. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
28296 |
1-[4-(difluoromethoxy)phenyl]-2-phenyl-1-ethanone
|
|
C15H12F2O2 |
详情 |
详情
|
(II) |
31225 |
1,7,7-trimethyl-2-phenylbicyclo[2.2.1]heptan-2-ol
|
|
C16H22O |
详情 |
详情
|
(III) |
11907 |
Dimethylaminoethyl chloride; 2-Dimethylaminoethyl chloride; 2-Chloro-N,N-dimethyl-1-ethanamine; N-(2-Chloroethyl)-N,N-dimethylamine
|
107-99-3 |
C4H10ClN |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(XIII) Synthesis of [14C]-labeled CI-980:
The reaction of N-(ethoxycarbonyl)-L-alanine (VII) with N-methoxy-N-methylamine (VIII) by means of carbonyldiimidazole (CDI) in THF/dichloromethane gives the corresponding amide (IX), which is treated with phenylmagnesium bromide (1 mol) yielding the bromomagnesium salt (X). The bromination of [14C]-labeled benzene (XI) with Br2/HBr/H2O2 gives the labeled bromobenzene (XII), which is converted into the corresponding Grignard reagent (XIII) by reaction with Mg and dibromoethane in ether. The reaction of the previously obtained magnesium salt of alaninamide (X) with the labeled Grignard reagent (XIII) affords the labeled carbamate (XIV), which is reduced with NaBH4 in methanol and treated with KOH giving a mixture of the oxazolidinone (XV) and the aminoalcohol (XVI), separated by acidic extraction. The hydrolysis of the oxazolidinone (XV) with KOH yielded the desired aminoalcohol (XVI). The aminoalcohol (XVI) by means of triethylamine in refluxing ethanol gives (1S,2R)-N-[2-amino-4-(2-hydroxy-1-methyl-2-phenylethylamino)-3-nitropyridin-6-yl]carbamic acid ethyl ester (XVII), which is oxidized with CrO3-pyridine in dichloromethane yielding the corresponding ketone (XVIII). The reductocyclization of (XVIII) with H2 over RaNi in glacial acetic acid affords the free base of title compound (XIX), which is finally treated with 2-hydroxyethanesulfonic acid in methanol.
【1】
Graul, A.; Martell, A.M.; Castaner, J.; Mivobulin Isethionate. Drugs Fut 1997, 22, 9, 980.
|
【2】
Woo, P.W.K.; Lee, H.T.; Synthesis of [14C]CI-980, ethyl [5-amino-1,2-dihydro-2(S)-methyl-3-[14C]phenylpyrido[3,4-b]pyrazin-7 -yl]carbamate isethionate salt, a tubulin-binding, antimitotic, broad-spectrum antitumor agent. J Label Compd Radiopharm 1994, 34, 1, 1-10. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
13359 |
2-Hydroxy-1-ethanesulfonic acid
|
107-36-8 |
C2H6O4S |
详情 | 详情
|
(VII) |
13360 |
(2S)-2-[(Ethoxycarbonyl)amino]propionic acid
|
|
C6H11NO4 |
详情 |
详情
|
(VIII) |
13361 |
(Methoxyamino)methane; N,O-Dimethylhydroxylamine
|
1117-97-1 |
C2H7NO |
详情 | 详情
|
(IX) |
13358 |
ethyl (2S)-5-amino-2-methyl-3-phenyl-1,2-dihydropyrido[3,4-b]pyrazin-7-ylcarbamate
|
|
C17H19N5O2 |
详情 |
详情
|
(IX) |
13362 |
ethyl (1S)-2-[methoxy(methyl)amino]-1-methyl-2-oxoethylcarbamate
|
|
C8H16N2O4 |
详情 |
详情
|
(X) |
13363 |
N-(Ethoxycarbonyl)-N-[1(S)-(N-methoxy-N-methylcarbamoyl)ethyl]amide anion
|
|
C8H15N2O4 |
详情 |
详情
|
(XI) |
13364 |
Benzene
|
71-43-2 |
C6H6 |
详情 | 详情
|
(XI) |
44622 |
|
|
C6H6 |
详情 |
详情
|
(XII) |
13365 |
Monobromobenzene; 1-Bromobenzene;Phenylbromide;bromobenzene |
108-86-1 |
C6H5Br |
详情 | 详情
|
(XII) |
45166 |
|
|
C6H5Br |
详情 |
详情
|
(XIII) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(XIII) |
45167 |
|
|
C6H5BrMg |
详情 |
详情
|
(XIV) |
13367 |
ethyl (1S)-1-methyl-2-oxo-2-phenylethylcarbamate
|
|
C12H15NO3 |
详情 |
详情
|
(XIV) |
45168 |
|
|
C12H15NO3 |
详情 |
详情
|
(XV) |
13368 |
(4S)-4-Methyl-5-phenyl-1,3-oxazolidin-2-one; (4S,5R)-(-)-4-Methyl-5-phenyl-2-oxazolidinone
|
16251-45-9 |
C10H11NO2 |
详情 | 详情
|
(XV) |
45169 |
|
|
C9H13NO |
详情 |
详情
|
(XVI) |
13355 |
2-Amino-1-phenyl-1-propanol; (1S,2R)-(+)-Norephedrine
|
37577-28-9 |
C9H13NO |
详情 | 详情
|
(XVI) |
45170 |
|
|
C10H11NO2 |
详情 |
详情
|
(XVII) |
13356 |
ethyl 6-amino-4-[[(1S,2R)-2-hydroxy-1-methyl-2-phenylethyl]amino]-5-nitro-2-pyridinylcarbamate
|
|
C17H21N5O5 |
详情 |
详情
|
(XVII) |
63746 |
|
|
C17H21N5O5 |
详情 |
详情
|
(XVIII) |
13357 |
ethyl 6-amino-4-[[(1S)-1-methyl-2-oxo-2-phenylethyl]amino]-5-nitro-2-pyridinylcarbamate
|
|
C17H19N5O5 |
详情 |
详情
|
(XVIII) |
63747 |
|
|
C17H19N5O5 |
详情 |
详情
|
(XIX) |
63748 |
|
|
C17H19N5O2 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) Treatment of anhydroecgonine methyl ester (I) with phenylmagnesium bromide (II) in Et2O affords a mixture of isomers from which phenyltropane derivative (III) is chromatographically separated. Nitration of (III) using nitronium tetrafluoroborate (NO2BF4) in acetonitrile provides derivative (IV), whose nitro group is then reduced by hydrogenation over Raney-Ni in MeOH to yield the p-amino derivative (V). Finally, the desired product is obtained by treatment of (V) with diiodomethane and isoamyl nitrite (VI).
【1】
Carroll, F.I.; et al.; Synthesis, ligand binding, QSAR, and CoMFA study of 3beta-(p-substituted phenyl)tropane-2beta-carboxylic acid methyl esters. J Med Chem 1991, 34, 9, 2719.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21118 |
methyl (1R,5S)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylate
|
|
C10H15NO2 |
详情 |
详情
|
(II) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(III) |
49502 |
methyl (1R,2S,3S,5S)-8-methyl-3-phenyl-8-azabicyclo[3.2.1]octane-2-carboxylate
|
|
C16H21NO2 |
详情 |
详情
|
(IV) |
49503 |
methyl (1R,2S,3S,5S)-8-methyl-3-(4-nitrophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate
|
|
C16H20N2O4 |
详情 |
详情
|
(V) |
49504 |
methyl (1R,2S,3S,5S)-3-(4-aminophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
|
|
C16H22N2O2 |
详情 |
详情
|
(VI) |
49505 |
Isoamyl nitrite; iso-Amyl Nitrite; 3-Methylbutyl Nitrite; iso-Pentyl Nitrite; Isopentyl nitrite; Amyl Nitrite
|
110-46-3 |
C5H11NO2 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(VI) In an alternative procedure, the reductive alkylation of 3-amino-2-chloropyridine (IV) with 2-methoxy-5-trifluoromethoxybenzaldehyde (III) in the presence of NaBH(OAc)3 produced the 3-(benzylamino)pyridine (V). The 2-phenyl pyridine derivative (VII) was then prepared by chloride displacement with phenylmagnesium bromide (VI) in the presence of bis(triphenylphosphino)nickel(II) chloride. Catalytic hydrogenation of pyridine (VII) produced the racemic cis-piperidine, which was finally resolved into the enantiomers by using (S)-mandelic acid.
【1】
Rosen, T.J.; Godek, D.M.; Ruggeri, S.G.; Wint, L.T. (Pfizer Inc.); Preparation of substd. piperidines. WO 9311110 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
59236 |
2-methoxy-5-(trifluoromethoxy)benzaldehyde
|
|
C9H7F3O3 |
详情 |
详情
|
(IV) |
11160 |
2-Chloro-3-pyridinamine; 2-Chloro-3-pyridinylamine; 3-Amino-2-chloropyridine; 2-Chloro-3-aminopyridine
|
6298-19-7 |
C5H5ClN2 |
详情 | 详情
|
(V) |
59237 |
N-(2-chloro-3-pyridinyl)-N-[2-methoxy-5-(trifluoromethoxy)benzyl]amine; 2-chloro-N-[2-methoxy-5-(trifluoromethoxy)benzyl]-3-pyridinamine
|
|
C14H12ClF3N2O2 |
详情 |
详情
|
(VI) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(VII) |
59238 |
N-[2-methoxy-5-(trifluoromethoxy)benzyl]-2-phenyl-3-pyridinamine; N-[2-methoxy-5-(trifluoromethoxy)benzyl]-N-(2-phenyl-3-pyridinyl)amine
|
|
C20H17F3N2O2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(III) Swern oxidation of 4-hydroxypiperidine-1-carboxylic acid tert-butyl ester (I) with oxalyl chloride in DMSO/dichloromethane gives the corresponding piperidone (II), which is submitted to a Grignard reaction with [U-14C]phenylmagnesium bromide (III) in THF to yield 4-hydroxy-4-phenylpiperidine-1-carboxylic acid tert-butyl ester (IV). The reaction of (IV) with BF3/Et2O in dichloromethane affords labeled 4-phenyl-1,2,3,6-tetrahydropyridine (V), which is condensed with 3-phenyl-3-cyclohexene-1(R)-carboxylic acid (VI) by means of HOBT, DCC and TEA in ethyl acetate to provide the labeled 1-(3-phenyl-3-cyclohexen-1(R)-yl)-1-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)methanone (VII). Finally, this compound is reduced with LiAlH4 and AlCl3 in THF to obtain the target tetrahydropyridine derivative.
【1】
Ekhato, I.V.; Huang, C.C.; Synthesis of (R)-(+)-1,2,3,6-tetrahydro-4-[U-14C]phenyl-1[(3-phenyl-3-cyclohexenyl-1-yl)methyl]pyridine, a potential antipsychotic agent. J Label Compd Radiopharm 1995, 36, 1, 57.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18625 |
tert-butyl 4-hydroxy-1-piperidinecarboxylate
|
|
C10H19NO3 |
详情 |
详情
|
(II) |
18620 |
tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone |
79099-07-3 |
C10H17NO3 |
详情 | 详情
|
(II) |
45167 |
|
|
C6H5BrMg |
详情 |
详情
|
(III) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(IV) |
57878 |
tert-butyl 4-hydroxy-4-phenyl-1-piperidinecarboxylate
|
|
C16H23NO3 |
详情 |
详情
|
(IV) |
64702 |
tert-butyl 4-hydroxy-4-phenyl-1-piperidinecarboxylate
|
|
C16H23NO3 |
详情 |
详情
|
(V) |
13002 |
4-Phenyl-1,2,3,6-tetrahydropyridine; 1,2,3,6-Tetrahydro-4-phenyl-pyridine
|
10338-69-9 |
C11H13N |
详情 | 详情
|
(V) |
64703 |
4-Phenyl-1,2,3,6-tetrahydro-pyridine |
10338-69-9 |
C11H13N |
详情 | 详情
|
(VI) |
57879 |
(1R)-3-phenyl-3-cyclohexene-1-carboxylic acid
|
|
C13H14O2 |
详情 |
详情
|
(VII) |
54955 |
[(1R)-3-phenyl-3-cyclohexen-1-yl][4-phenyl-3,6-dihydro-1(2H)-pyridinyl]methanone
|
|
C24H25NO |
详情 |
详情
|
(VII) |
64704 |
[(1R)-3-phenyl-3-cyclohexen-1-yl][4-phenyl-3,6-dihydro-1(2H)-pyridinyl]methanone
|
|
C24H25NO |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VI) The reaction of 7-amino-4,4-dimethyl-1,2,3,4-tetrahydronaphthalen-1-one (I) with NaNO2 and BF4H in water gives the corresponding diazo compound (II), which is treated with H2SO4 in refluxing water yielding 7-hydroxy-4,4-dimethyl-1,2,3,4-tetrahydronaphthalen-1-one (III). The reaction of (III) with trifluoromethanesulfonic anhydride in pyridine affords the expected sulfonate (IV), which is carboxylated with CO, PdAc2 and 1,3-bis(diphenylphosphino)propane in methanol/DMSO yielding 5,5-dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid methyl ester (V). The Grignard condensation of (V) with phenylmagnesium bromide (VI) in THF affords the corresponding addition product (VII), which is dehydrated with p-toluenesulfonic acid in hot toluene affording the dihydronaphtoic ester (VIII). The hydrolysis of (VIII) with NaOH in ethanol gives the corresponding free acid (IX), which is treated with SOCl2 and DMF yielding the expected acyl chloride (X). The condensation of (X) with methyl 4-aminobenzoate (XI) in pyridine affords the expected amide (XII), which is finally hydrolyzed to the target compound with NaOH in ethanol/water.
【1】
Starrett, J.E. Jr.; Yu, K.-L.; Mansuri, M.M.; Tortolani, D.R. (Bristol-Myers Squibb Co.); Substd. (5,6)-dihydronaphthalenyl cpds. having retinoid-like activity. CA 2138000; EP 0661259; JP 1995242591; US 5648385 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27269 |
7-amino-4,4-dimethyl-3,4-dihydro-1(2H)-naphthalenone
|
|
C12H15NO |
详情 |
详情
|
(II) |
27793 |
5,5-Dimethyl-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yldiazonium tetrafluoroborate
|
|
C12H13BF4N2O |
详情 |
详情
|
(III) |
27794 |
7-hydroxy-4,4-dimethyl-3,4-dihydro-1(2H)-naphthalenone
|
|
C12H14O2 |
详情 |
详情
|
(IV) |
27795 |
5,5-dimethyl-8-oxo-5,6,7,8-tetrahydro-2-naphthalenyl trifluoromethanesulfonate
|
|
C13H13F3O4S |
详情 |
详情
|
(V) |
27796 |
methyl 5,5-dimethyl-8-oxo-5,6,7,8-tetrahydro-2-naphthalenecarboxylate
|
|
C14H16O3 |
详情 |
详情
|
(VI) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(VII) |
27797 |
methyl 8-hydroxy-5,5-dimethyl-8-phenyl-5,6,7,8-tetrahydro-2-naphthalenecarboxylate
|
|
C20H22O3 |
详情 |
详情
|
(VIII) |
27798 |
methyl 5,5-dimethyl-8-phenyl-5,6-dihydro-2-naphthalenecarboxylate
|
|
C20H20O2 |
详情 |
详情
|
(IX) |
27799 |
5,5-dimethyl-8-phenyl-5,6-dihydro-2-naphthalenecarboxylic acid
|
|
C19H18O2 |
详情 |
详情
|
(X) |
27800 |
5,5-dimethyl-8-phenyl-5,6-dihydro-2-naphthalenecarbonyl chloride
|
|
C19H17ClO |
详情 |
详情
|
(XI) |
20537 |
methyl 4-aminobenzoate
|
619-45-4 |
C8H9NO2 |
详情 | 详情
|
(XII) |
27801 |
methyl 4-[[(5,5-dimethyl-8-phenyl-5,6-dihydro-2-naphthalenyl)carbonyl]amino]benzoate
|
|
C27H25NO3 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(IV) Reductive condensation of 3-amino-2-chloropyridine (I) with 5-isopropylbenzofuran-7-carbaldehyde (II) in the presence of sodium triacetoxyborohydride provided secondary amine (III). Displacement of the chlorine atom of (III) with phenylmagnesium bromide (IV) using NiCl2 produced phenylpyridine (V), which was hydrogenated with hydrogen over PtO2 in acetic acid to give racemic piperidine (VI). Resolution of (VI) with (R)-(-)-mandelic acid yielded the (2S,3S)-isomer, which was finally isolated as the dihydrochloride salt.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11160 |
2-Chloro-3-pyridinamine; 2-Chloro-3-pyridinylamine; 3-Amino-2-chloropyridine; 2-Chloro-3-aminopyridine
|
6298-19-7 |
C5H5ClN2 |
详情 | 详情
|
(II) |
26501 |
5-isopropyl-2,3-dihydro-1-benzofuran-7-carbaldehyde
|
|
C12H14O2 |
详情 |
详情
|
(III) |
26502 |
2-chloro-N-[(5-isopropyl-2,3-dihydro-1-benzofuran-7-yl)methyl]-3-pyridinamine
|
|
C17H19ClN2O |
详情 |
详情
|
(IV) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(V) |
26503 |
N-[(5-isopropyl-2,3-dihydro-1-benzofuran-7-yl)methyl]-2-phenyl-3-pyridinamine
|
|
C23H24N2O |
详情 |
详情
|
(VI) |
26504 |
N-[(5-isopropyl-2,3-dihydro-1-benzofuran-7-yl)methyl]-2-phenyl-3-piperidinamine
|
|
C23H30N2O |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(A) The esterification of 4,4-bis(4-hydroxyphenyl)pentanoic acid (I) with diazomethane in ethyl ether/methanol gives the methyl ester (II), which is treated with phenylmagnesium bromide in THF to yield 4,4-bis(4-hydroxyphenyl)-1,1-diphenyl-1-pentanol (III). The reduction of (III) with H2 over Pd/C in methanol affords 4,4-bis(4-hydroxyphenyl)-1,1-diphenylpentane (IV), which is finally condensed with azepane (V) and formaldehyde in hot ethanol/water.
【1】
Yuen, P.-w.; Malone, T.C.; Tarczy-Hornoch, K.; Rock, D.M.; Szoke, B.; Stoehr, S.; Schelkun, R.M.; Synthesis and biological activity of substituted bis-(4-hydroxyphenyl)methanes as N-type calcium channel blockers. Bioorg Med Chem Lett 1999, 9, 16, 2447. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
22391 |
4,4-bis(4-hydroxyphenyl)pentanoic acid
|
126-00-1 |
C17H18O4 |
详情 | 详情
|
(II) |
22392 |
methyl 4,4-bis(4-hydroxyphenyl)pentanoate
|
|
C18H20O4 |
详情 |
详情
|
(III) |
31669 |
4-[4-hydroxy-1-(4-hydroxyphenyl)-1-methyl-4,4-diphenylbutyl]phenol
|
|
C29H28O3 |
详情 |
详情
|
(IV) |
31670 |
4-[1-(4-hydroxyphenyl)-1-methyl-4,4-diphenylbutyl]phenol
|
|
C29H28O2 |
详情 |
详情
|
(V) |
18672 |
azepane
|
111-49-9 |
C6H13N |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
Ethyl levulinate (I) was reacted with one equivalent of methylmagnesium bromide to produce 5,5-dimethyldihydrofuran-2-one (II). Friedel-Crafts condensation of (III) with benzene in the presence of AlCl3 afforded 4,4-dimethyl-1-tetralone (III) which, after nitration and reduction furnished the aminotetralone (V). This was converted to iodide (VI) upon diazotization, followed by treatment with KI. Methyl 4-vinylbenzoate (VIII) was obtained by alkylation of the corresponding carboxylic acid (VII) with MeI in the presence of DBU. Coupling of this olefin (VIII) with iodide (VI) was carried out using palladium diacetate and tetrabutylammonium chloride at 70 C to yield the diaryl ethylene derivative (IX). Subsequent addition of phenylmagnesium bromide to (IX) produced the tertiary alcohol (X). Finally, dehydration of (X) using p-toluenesulfonic acid, followed by basic hydrolysis, provided the title compound.
【1】
Starrett, J.E. Jr.; Yu, K.-L.; Mansuri, M.M.; Tortolani, D.R. (Bristol-Myers Squibb Co.); Substd. (5,6)-dihydronaphthalenyl cpds. having retinoid-like activity. CA 2138000; EP 0661259; JP 1995242591; US 5648385 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
27267 |
ethyl 4-oxopentanoate
|
539-88-8 |
C7H12O3 |
详情 | 详情
|
(II) |
23768 |
5,5-dimethyldihydro-2(3H)-furanone
|
|
C6H10O2 |
详情 |
详情
|
(III) |
23791 |
4,4-dimethyl-3,4-dihydro-1(2H)-naphthalenone
|
2979-69-3 |
C12H14O |
详情 | 详情
|
(IV) |
27268 |
4,4-dimethyl-7-nitro-3,4-dihydro-1(2H)-naphthalenone
|
|
C12H13NO3 |
详情 |
详情
|
(V) |
27269 |
7-amino-4,4-dimethyl-3,4-dihydro-1(2H)-naphthalenone
|
|
C12H15NO |
详情 |
详情
|
(VI) |
27270 |
7-iodo-4,4-dimethyl-3,4-dihydro-1(2H)-naphthalenone
|
|
C12H13IO |
详情 |
详情
|
(VII) |
27271 |
4-vinylbenzoic acid
|
1075-49-6 |
C9H8O2 |
详情 | 详情
|
(VIII) |
27272 |
methyl 4-vinylbenzoate
|
|
C10H10O2 |
详情 |
详情
|
(IX) |
27273 |
methyl 4-[(E)-2-(5,5-dimethyl-8-oxo-5,6,7,8-tetrahydro-2-naphthalenyl)ethenyl]benzoate
|
|
C22H22O3 |
详情 |
详情
|
(X) |
27274 |
methyl 4-[(E)-2-(8-hydroxy-5,5-dimethyl-8-phenyl-5,6,7,8-tetrahydro-2-naphthalenyl)ethenyl]benzoate
|
|
C28H28O3 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
Dipolar cycloaddition of hydroxypyridinium betaine (I) with R-(+)-p-tolyl vinyl sulfoxide (II) furnished the chiral tropenone (III). Subsequent copper-catalyzed conjugate addition of phenyl-magnesium bromide on the beta-face of (III) provided the trans diaryltropanone (IV). Then, ketone reduction of (IV) with LiAlH4 gave alcohol (V), which was condensed with phenyl thionochloroformate (VI) to afford thiocarbonate (VII). This was reduced with tributyltin hydride and azobis(isobutyronitrile) to produce tropane (VIII). The sulfoxide group of (VIII) was further reduced to sulfide (IX) with PCl3 in DMF. Finally, Raney Nickel-promoted desulfurization in boiling EtOH yielded the title compound.
【1】
Kozikowski, A.P.; Araldi, G.L.; Prakash, K.R.; Zhang, M.; Johnson, K.M.; Synthesis and biological properties of new 2beta-alkyl- and 2beta-aryl-3-(substituted phenyl)tropane derivatives: Stereochemical effect of C-3 on affinity and selectivity for neuronal dopamine and serotonin transporters. J Med Chem 1998, 41, 25, 4973. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
25800 |
1-methyl-4-(4-methylphenyl)-3-pyridiniumolate
|
|
C13H13NO |
详情 |
详情
|
(II) |
25801 |
(4-methylphenyl)(oxo)vinyl-lambda(4)-sulfane; 4-methylphenyl vinyl sulfoxide
|
|
C9H10OS |
详情 |
详情
|
(III) |
25802 |
(1S,5S,6R)-8-methyl-3-(4-methylphenyl)-6-[(4-methylphenyl)sulfinyl]-8-azabicyclo[3.2.1]oct-3-en-2-one
|
|
C22H23NO2S |
详情 |
详情
|
(IV) |
25803 |
(1S,3R,4R,5S,6R)-8-methyl-3-(4-methylphenyl)-6-[(4-methylphenyl)sulfinyl]-4-phenyl-8-azabicyclo[3.2.1]octan-2-one
|
|
C28H29NO2S |
详情 |
详情
|
(V) |
25804 |
(1S,3R,4R,5S,6R)-8-methyl-3-(4-methylphenyl)-6-[(4-methylphenyl)sulfinyl]-4-phenyl-8-azabicyclo[3.2.1]octan-2-ol
|
|
C28H31NO2S |
详情 |
详情
|
(VI) |
25805 |
1-[(chlorocarbothioyl)oxy]benzene; Phenylchlorothioformate
|
1005-56-7 |
C7H5ClOS |
详情 | 详情
|
(VII) |
25806 |
O-[(1S,3R,4R,5S,6R)-8-methyl-3-(4-methylphenyl)-6-[(4-methylphenyl)sulfinyl]-4-phenyl-8-azabicyclo[3.2.1]oct-2-yl] O-phenyl carbonothioate
|
|
C35H35NO3S2 |
详情 |
详情
|
(VIII) |
25807 |
(1R,3R,4R,5S,6R)-8-methyl-3-(4-methylphenyl)-4-phenyl-8-azabicyclo[3.2.1]oct-6-yl 4-methylphenyl sulfoxide; (1S,2R,3R,5R,7R)-8-methyl-3-(4-methylphenyl)-7-[(4-methylphenyl)sulfinyl]-2-phenyl-8-azabicyclo[3.2.1]octane
|
|
C28H31NOS |
详情 |
详情
|
(IX) |
25808 |
(1R,3R,4R,5S,6R)-8-methyl-3-(4-methylphenyl)-4-phenyl-8-azabicyclo[3.2.1]oct-6-yl 4-methylphenyl sulfide; (1S,2R,3R,5R,7R)-8-methyl-3-(4-methylphenyl)-7-[(4-methylphenyl)sulfanyl]-2-phenyl-8-azabicyclo[3.2.1]octane
|
|
C28H31NS |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
Addition of phenylmagnesium bromide to 6-methoxy-1-indanone (I) gave carbinol (II), which was dehydrated to phenylindene (III) upon treatment with p-toluenesulfonic acid in refluxing toluene. Oxidative cleavage of (III) with Jones reagent in the presence of OsO4 provided 2-benzoyl-4-methoxyphenylacetic acid (IV), which was further reduced to the 2-benzyl analogue (V) by hydrogenation over Pd/C. After conversion of (V) to the corresponding acid chloride (VI) using oxalyl chloride and a trace of DMF, Friedel-Crafts cyclization with AlCl3 furnished the dibenzocycloheptenone (VII). Addition of the lithium enolate of ethyl acetate to the carbonyl group of (VII) in the presence of tetramethylethylenediamine at -78 C generated the hydroxyester (VIII). Then, hydrogenolysis of the benzylic alcohol of (VIII) in the presence of Pd/C gave (IX). Subsequent cleavage of the methyl ether of (IX) by means of ethane thiol and AlCl3 provided the corresponding racemic phenol. Isolation of the required (S)-enantiomer (X) was carried out by chiral HPLC.
【1】
Drake, F.H. (SmithKline Beecham plc); Method for stimulating bone formation. EP 0946180; WO 9815278 .
|
【2】
Miller, W.H.; Samanen, J.M.; Heerding, D.; Bondinell, W.E. (SmithKline Beecham Corp.); Vitronectin receptor antagonists. EP 1025090; WO 9915508 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
17491 |
ethyl acetate
|
141-78-6 |
C4H8O2 |
详情 | 详情
|
|
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(I) |
34514 |
6-methoxy-1-indanone
|
13623-25-1 |
C10H10O2 |
详情 | 详情
|
(II) |
34515 |
6-methoxy-1-phenyl-1-indanol
|
|
C16H16O2 |
详情 |
详情
|
(III) |
34516 |
5-methoxy-3-phenyl-1H-indene; methyl 3-phenyl-1H-inden-5-yl ether
|
|
C16H14O |
详情 |
详情
|
(IV) |
34517 |
2-(2-benzoyl-4-methoxyphenyl)acetic acid
|
|
C16H14O4 |
详情 |
详情
|
(V) |
34518 |
2-(2-benzyl-4-methoxyphenyl)acetic acid
|
|
C16H16O3 |
详情 |
详情
|
(VI) |
34519 |
2-(2-benzyl-4-methoxyphenyl)acetyl chloride
|
|
C16H15ClO2 |
详情 |
详情
|
(VII) |
34520 |
3-methoxy-5,11-dihydro-10H-dibenzo[a,d]cyclohepten-10-one
|
|
C16H14O2 |
详情 |
详情
|
(VIII) |
34521 |
ethyl 2-(10-hydroxy-3-methoxy-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-yl)acetate
|
|
C20H22O4 |
详情 |
详情
|
(IX) |
34522 |
ethyl 2-(3-methoxy-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-yl)acetate
|
|
C20H22O3 |
详情 |
详情
|
(X) |
34523 |
ethyl 2-[(10S)-3-hydroxy-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-10-yl]acetate
|
|
C19H20O3 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
The Grignard reaction of vinyloxirane (I) with phenylmagnesium bromide and CuCN in THF gives 4-phenyl-2-buten-1-ol (II), which is submitted to a Sharpless epoxidation with t-BuOOH and Ti(Oi-Pr)4 in dichloromethane in the presence of (-)-diethyl tartrate [(-)-DET] yielding the chiral epoxide (III). The reaction of (III) with Ti(Oi-Pr)2(N3)2 in refluxing benzene affords the 3(S)-azido-4-phenylbutane-1,2(S)-diol (IV), which is epoxidized with 2-acetoxy-2-methylpropionyl chloride (A) and NaOMe in THF to give the chiral azidoepoxide (V). The reaction of (V) with isobutylamine (VI) in hot isopropanol yields the secondary amine (VII), which is condensed with 4-methoxyphenylsulfonyl chloride (VIII) in pyridine affording the sulfonamide (IX). The reduction of the azido group of (IX) with H2 over Pd/C in methanol provides (X) with a primary amino group that is finally condensed with the succinimidinyl carbonate (XI) by means of triethylamine in acetonitrile.
【1】
Ghosh, A.K.; Kincaid, J.F.; Cho, W.; Walters, D.E.; Krishnan, K.; Hussain, K.A.; Koo, Y.; Cho, H.; Rudall, C.; Holland, L.; Buthod, J.; Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere. Bioorg Med Chem Lett 1998, 8, 6, 687. |
【2】
Hussain, K.A.; Gulnik, S.V.; Ghosh, A.K.; Erickson, J.W. (University of Illinois; US Department of Health & Human Services); Multi-drug resistant retroviral protease inhibitors and associated methods. WO 9967254 .
|
【3】
Ghosh, A.K.; et al.; Potent HIV protease inhibitors: The development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands. J Med Chem 1993, 36, 16, 2300.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(A) |
32808 |
2-chloro-1,1-dimethyl-2-oxoethyl acetate
|
40635-66-3 |
C6H9ClO3 |
详情 | 详情
|
(I) |
32805 |
2-vinyloxirane
|
930-22-3 |
C4H6O |
详情 | 详情
|
(II) |
32806 |
(E)-4-phenyl-2-buten-1-ol
|
|
C10H12O |
详情 |
详情
|
(III) |
32807 |
[(2R,3S)-3-benzyloxiranyl]methanol
|
116949-62-3 |
C10H12O2 |
详情 | 详情
|
(IV) |
14544 |
(2S,3S)-3-azido-4-phenyl-1,2-butanediol
|
|
C10H13N3O2 |
详情 |
详情
|
(V) |
14547 |
(1S)-1-[(2S)oxiranyl]-2-phenylethyl azide; (2S)-2-[(1S)-1-azido-2-phenylethyl]oxirane
|
|
C10H11N3O |
详情 |
详情
|
(VI) |
13306 |
2-Methyl-1-propanamine; Isobutylamine
|
78-81-9 |
C4H11N |
详情 | 详情
|
(VII) |
32809 |
(2R,3S)-3-azido-1-(isobutylamino)-4-phenyl-2-butanol
|
|
C14H22N4O |
详情 |
详情
|
(VIII) |
15719 |
4-methoxybenzenesulfonyl chloride
|
98-68-0 |
C7H7ClO3S |
详情 | 详情
|
(IX) |
32810 |
N-[(2R,3S)-3-azido-2-hydroxy-4-phenylbutyl]-N-isobutyl-4-methoxybenzenesulfonamide
|
|
C21H28N4O4S |
详情 |
详情
|
(X) |
32811 |
N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-isobutyl-4-methoxybenzenesulfonamide
|
|
C21H30N2O4S |
详情 |
详情
|
(XI) |
32812 |
1-([[(3R,3aS,6aR)hexahydrofuro[2,3-b]furan-3-yloxy]carbonyl]oxy)-2,5-pyrrolidinedione
|
|
C11H13NO7 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(XXIII) Condensation of desoxybenzoin (I) with 2-(tetra-hydropyranyloxy)ethyl bromide (XIV) by means of aqueous NaOH and TEBAC as before gives 1,2-diphenyl-4-(tetrahydropyranyloxy)-1-butanone (XV), which by a Grignard condensation with 4-methoxyphenylmagnesium bromide (XVI) -prepared from 4-bromoanisole (XVII) and Mg in THF- provides the triphenylbutanol derivative (XVIII). Cleavage of the THP-protecting group of compound (XVIII) with H2SO4 in ethanol/water at room temperature affords the butane-1,4-diol derivative (XIX), which is cyclized by means of H2SO4 in hot ethanol/ water to yield 2-(4-methoxyphenyl)-2,3-diphenyltetrahydrofuran (XX). Finally, this compound is treated with 48% HBr in refluxing AcOH to give 4-(4-hydroxyphenyl)-3,4-diphenyl-3-buten-1-ol (X) as a (Z):(E)-isomeric mixture, from which the desired (Z)-isomer is separated by chemical work up.
【1】
Sorbera, L.A.; Castaner, J.; Bayes, M.; Ospemifene. Drugs Fut 2004, 29, 1, 38.
|
【2】
Toivola, R.J.; Karjalainen, A.J.; Kurkela, K.O.A.; Soderwall, M.-L.; Kangas, L.V.M.; Blanco, G.L.; Sundquist, H.K. (Orion Corporation); Tri-phenyl alkene derivs. and their oestrogenic, anti-oestrogenic and progestanic uses. US 4996225; US 5491173 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41003 |
1,2-diphenyl-1-ethanone; Deoxybenzoin-2-phenylacetophenone; Dexybenzoin
|
451-40-1 |
C14H12O |
详情 | 详情
|
(X) |
52025 |
4-[(Z)-4-hydroxy-1,2-diphenyl-1-butenyl]phenol
|
|
C22H20O2 |
详情 |
详情
|
(XIV) |
26934 |
2-bromoethyl tetrahydro-2H-pyran-2-yl ether
|
|
C7H13BrO2 |
详情 |
详情
|
(XV) |
52021 |
1,2-diphenyl-4-(tetrahydro-2H-pyran-2-yloxy)-1-butanone
|
|
C21H24O3 |
详情 |
详情
|
(XVI) |
37674 |
Bromo(4-methoxyphenyl)magnesium; 4-Methoxyphenylmagnesium bromide
|
352-13-6 |
C7H7BrMgO |
详情 | 详情
|
(XVII) |
63436 |
1-bromo-4-methoxybenzene; 4-bromophenyl methyl ether
|
|
C7H7BrO |
详情 |
详情
|
(XVIII) |
52022 |
1-(4-methoxyphenyl)-1,2-diphenyl-4-(tetrahydro-2H-pyran-2-yloxy)-1-butanol
|
|
C28H32O4 |
详情 |
详情
|
(XIX) |
52023 |
1-(4-methoxyphenyl)-1,2-diphenyl-1,4-butanediol
|
|
C23H24O3 |
详情 |
详情
|
(XX) |
52024 |
2-(4-methoxyphenyl)-2,3-diphenyltetrahydrofuran; 4-(2,3-diphenyltetrahydro-2-furanyl)phenyl methyl ether
|
|
C23H22O2 |
详情 |
详情
|
(XXI) |
30343 |
1-(4-methoxyphenyl)-2-phenyl-1-ethanone
|
|
C15H14O2 |
详情 |
详情
|
(XXII) |
63437 |
1-(4-methoxyphenyl)-2-phenyl-4-(tetrahydro-2H-pyran-2-yloxy)-1-butanone
|
|
C22H26O4 |
详情 |
详情
|
(XXIII) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) The Grignard condensation of 4,4'-difluorobenzophenone (I) with phenylmagnesium bromide (II) in refluxing tert-butyl methyl ether gives the corresponding carbinol (III), which is treated with acetyl chloride in dichloromethane to yield the methyl chloride (IV). Condensation of compound (IV) with copper cyanide by heating at 140 °C, followed by treatment with hot toluene affords 2,2-bis(4-fluorophenyl)-2-phenylacetonitrile (V), which is finally partially hydrolyzed with H2SO4 in refluxing glacial acetic acid.
【1】
Chilman-Blair, K.; Castaner, J.; Leeson, P.A.; ICA-17043. Drugs Fut 2003, 28, 9, 854.
|
【2】
Rigdon, G.C.; McNaughton-Smith, G.A.; Stocker, J.W. (ICAgen, Inc.); Gardos channel antagonists. EP 1158971; US 6288122; WO 0050026 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45633 |
bis(4-fluorophenyl)methanone; 4,4'-Difluorobenzophenone
|
345-92-6 |
C13H8F2O |
详情 | 详情
|
(II) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(III) |
62899 |
bis(4-fluorophenyl)(phenyl)methanol
|
|
C19H14F2O |
详情 |
详情
|
(IV) |
62900 |
1-[chloro(4-fluorophenyl)phenylmethyl]-4-fluorobenzene
|
|
C19H13ClF2 |
详情 |
详情
|
(V) |
62901 |
2,2-bis(4-fluorophenyl)-2-phenylacetonitrile
|
|
C20H13F2N |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(VII) Conjugate addition of methyl acrylate (II) to 3-methoxybenzaldehyde (I) under reversion of reactivity conditions in the presence of KCN produced the keto ester (III). The Wolff-Kishner reduction of the keto group caused simultaneous ester hydrolysis, yielding acid (IV), which was further cyclized to the tetralone (V) employing hot polyphosphoric acid. Mannich reaction of ketone (V) with N-benzyl methylamine and paraformaldehyde furnished amino ketone (VI). To this was added phenylmagnesium bromide (VII), yielding amino alcohol (VIII), which was subsequently dehydrated to (IX) by means of trifluoroacetic acid. Catalytic hydrogenation of the olefin double bond of (IX) with simultaneous N-benzyl group hydrogenolysis gave the secondary amine (X). This was then alkylated with ethyl bromoacetate, producing the substituted glycine ester (XI), which was finally hydrolyzed by means of LiOH.
【1】
Jaap, D.R.; Gilfillan, R.; Gibson, S.G.; Thorn, S.N. (Akzo Nobel N.V.); Aminomethylcarboxylic acid derivs.. EP 1100769; WO 0007978 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20589 |
3-methoxybenzaldehyde; m-Anisaldehyde
|
591-31-1 |
C8H8O2 |
详情 | 详情
|
(II) |
14156 |
methyl acrylate
|
96-33-3 |
C4H6O2 |
详情 | 详情
|
(III) |
51352 |
methyl 4-(3-methoxyphenyl)-4-oxobutanoate
|
|
C12H14O4 |
详情 |
详情
|
(IV) |
51353 |
4-(3-methoxyphenyl)butyric acid
|
|
C11H14O3 |
详情 |
详情
|
(V) |
17594 |
6-methoxy-3,4-dihydro-1(2H)-naphthalenone; 6-Methoxytetralone; 6-Methoxy-1-tetralone; 3,4-dihydro-6-methoxy-1(2H)-naphthalenone
|
1078-19-9 |
C11H12O2 |
详情 | 详情
|
(VI) |
51354 |
2-[[benzyl(methyl)amino]methyl]-6-methoxy-3,4-dihydro-1(2H)-naphthalenone
|
|
C20H23NO2 |
详情 |
详情
|
(VII) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(VIII) |
51355 |
2-[[benzyl(methyl)amino]methyl]-6-methoxy-1-phenyl-1,2,3,4-tetrahydro-1-naphthalenol
|
|
C26H29NO2 |
详情 |
详情
|
(IX) |
51356 |
N-benzyl(6-methoxy-1-phenyl-3,4-dihydro-2-naphthalenyl)-N-methylmethanamine; N-benzyl-N-[(6-methoxy-1-phenyl-3,4-dihydro-2-naphthalenyl)methyl]-N-methylamine
|
|
C26H27NO |
详情 |
详情
|
(X) |
51357 |
[(1S,2R)-6-methoxy-1-phenyl-1,2,3,4-tetrahydro-2-naphthalenyl]-N-methylmethanamine; N-[[(1S,2R)-6-methoxy-1-phenyl-1,2,3,4-tetrahydro-2-naphthalenyl]methyl]-N-methylamine
|
|
C19H23NO |
详情 |
详情
|
(XI) |
51358 |
ethyl 2-[[[(1S,2R)-6-methoxy-1-phenyl-1,2,3,4-tetrahydro-2-naphthalenyl]methyl](methyl)amino]acetate
|
|
C23H29NO3 |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(XII) The reaction of butadiene monooxide (XI) with phenylmagnesium bromide (XII) and CuCN in THF gives trans-4-phenyl-2-buten-1-ol (XIII), which is enantioselectively epoxidated with Ti(O-iPr)4, diethyl D-tartrate and tBu-OOH to yield the (2R,3R)-epoxide (XIV). The reaction of (XIV) with Ti(O-iPr)4 and N3-SiMe3 in refluxing benzene affords the chiral azidodiol (XV), which is epoxidated by means of 2-acetoxyisobutyryl chloride (AcBCl) and NaOMe in THF to provide the chiral azidoepoxide (XVI) (1). Opening of the epoxide ring of (XVI) with isobutylamine (XVII) in hot isopropanol gives the secondary amine (XVIII), which is acylated with 4-aminophenylsulfonyl chloride (XIX) and pyridine in dichloromethane to yield the corresponding sulfonamide (XX). The reduction of the azido group of (XX) with H2 over Pd/C in THF/methanol/HOAc affords the expected primary amine (XXI), which is finally condensed with the already reported intermediate (X) in dichloromethane to provide the target carbamate.
【1】
Ghosh, A.K.; Kincaid, J.F.; Cho, W.; Walters, D.E.; Krishnan, K.; Hussain, K.A.; Koo, Y.; Cho, H.; Rudall, C.; Holland, L.; Buthod, J.; Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere. Bioorg Med Chem Lett 1998, 8, 6, 687. |
【2】
Hussain, K.A.; Gulnik, S.V.; Ghosh, A.K.; Erickson, J.W. (University of Illinois; US Department of Health & Human Services); Multi-drug resistant retroviral protease inhibitors and associated methods. WO 9967254 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(X) |
32812 |
1-([[(3R,3aS,6aR)hexahydrofuro[2,3-b]furan-3-yloxy]carbonyl]oxy)-2,5-pyrrolidinedione
|
|
C11H13NO7 |
详情 |
详情
|
(XI) |
32805 |
2-vinyloxirane
|
930-22-3 |
C4H6O |
详情 | 详情
|
(XII) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(XIII) |
32806 |
(E)-4-phenyl-2-buten-1-ol
|
|
C10H12O |
详情 |
详情
|
(XIV) |
53549 |
[(2R,3R)-3-benzyloxiranyl]methanol
|
n/a |
C10H12O2 |
详情 | 详情
|
(XV) |
14544 |
(2S,3S)-3-azido-4-phenyl-1,2-butanediol
|
|
C10H13N3O2 |
详情 |
详情
|
(XVI) |
14547 |
(1S)-1-[(2S)oxiranyl]-2-phenylethyl azide; (2S)-2-[(1S)-1-azido-2-phenylethyl]oxirane
|
|
C10H11N3O |
详情 |
详情
|
(XVII) |
13306 |
2-Methyl-1-propanamine; Isobutylamine
|
78-81-9 |
C4H11N |
详情 | 详情
|
(XVIII) |
32809 |
(2R,3S)-3-azido-1-(isobutylamino)-4-phenyl-2-butanol
|
|
C14H22N4O |
详情 |
详情
|
(XIX) |
53550 |
4-aminobenzenesulfonyl chloride
|
98-62-4 |
C6H6ClNO2S |
详情 | 详情
|
(XX) |
53551 |
4-amino-N-[(2R,3S)-3-azido-2-hydroxy-4-phenylbutyl]-N-isobutylbenzenesulfonamide
|
n/a |
C20H27N5O3S |
详情 | 详情
|
(XXI) |
45533 |
4-amino-N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-isobutylbenzenesulfonamide
|
|
C20H29N3O3S |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(VII) Addition of phenylmagnesium bromide (VII) to cyanuric chloride (VI) provided 2,4-dichloro-6-phenyltriazine (VIII). This was subsequently condensed with aniline (V) to afford the aminotriazine (IX). Finally, displacement of the remaining chlorine of (IX) with 2-(3-pyridyl)ethylamine (X) furnished the target diaminotriazine derivative.
【1】
Murali Dhar, T.G.; Pitts, W.J.; Guo, J.; et al.; Rapid synthesis of novel inosine monophosphate dehydrogenase (IMPDH) inhibitors. 223rd ACS Natl Meet (April 7 2002, Orlando) 2002, Abst MEDI 214.
|
【2】
Liu, C.; Leftheris, K.; Pitts, W.J.; Iwanowicz, E.J.; Dhar, T.G.M.; Gu, H.H. (Bristol-Myers Squibb Co.); Cpds. derived from an amine nucleus that are inhibitors of IMPDH enzyme. EP 1126843; US 6399773; WO 0025780 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
39658 |
|
|
C10H10N2O2 |
详情 |
详情
|
(VI) |
23813 |
2,4,6-Trichloro-s-triazine; Cyanuric chloride; Trichlorocyanidine; Tricyanogen chloride; 2,4,6-Trichloro-1,3,5-triazine
|
108-77-0 |
C3Cl3N3 |
详情 | 详情
|
(VII) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(VIII) |
53552 |
4,6-Dichloro-2-phenyltriazine
|
1700-02-3 |
C9H5Cl2N3 |
详情 | 详情
|
(IX) |
53553 |
N-(4-chloro-6-phenyl-1,3,5-triazin-2-yl)-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]amine; 4-chloro-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-6-phenyl-1,3,5-triazin-2-amine
|
n/a |
C19H14ClN5O2 |
详情 | 详情
|
(X) |
53554 |
2-(3-Pyridyl)ethylamine; 3-(2-Aminoethyl)pyridine
|
20173-24-4 |
C7H10N2 |
详情 | 详情
|
合成路线21
该中间体在本合成路线中的序号:
(II) Elesclomol can be prepared as follows. The precursor thiobenzoic acid N-methylhydrazide (III) can be obtained by either treatment of carboxymethyl dithiobenzoate (I) with methylhydrazine under alkaline conditions or by reaction of phenylmagnesium bromide (II) with carbon disulfide, followed by treatment with methylhydrazine. Then, dimerization of thiohydrazide (III) with malonic acid in the presence of DCC/HOBt, or with malonyl dichloride or malonic acid diphenyl ester, provides the target malonohydrazide derivative (1, 2). Conversion of elesclomol to different salts (including sodium, potassium, lithium, calcium, magnesium, ethanolamine and choline salts) has also been reported (3). Scheme 1.
【1】
Chen, S., Sun, L., Ono, M., Koya, K., Xia, Z.-Q. (SBR Pharmaceuticals Corp.). Synthesis of taxol enhancers. US 2003069225, US 6825235, WO 03006429. |
【2】
Koya, K., Sun, L., Ono, M., Tatsuta, N., Wu, Y., Chen, S. (Synta Pharmaceuticals Corp.). Taxol enhancer compounds. EP 1406869, EP 1731148, JP 2004534848, US 2003119914, WO 03006430. |
【3】
Kostik, E., Vaghefi, F., Liang, G. et al. (Synta Pharmaceuticals Corp.). EP 1781604, WO 2006009940. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
65625 |
2-(Benzothioylthio)acetic acid; S-(Thiobenzoyl)thioglycolic acid; Dithiobenzoic acid carboxymethyl ester |
942-91-6 |
C9H8O2S2 |
详情 | 详情
|
(II) |
17616 |
bromo(phenyl)magnesium; Phenyl Magnesium Bromide
|
100-58-3 |
C6H5BrMg |
详情 | 详情
|
(III) |
65626 |
N-Methyl-N-thiobenzoylhydrazine; Thiobenzoic acid 1-methylhydrazide |
21048-05-5 |
C8H10N2S |
详情 | 详情
|